"This research was commissioned to inform when NICE should approve health technologies only in research (OIR) or with research (AWR)."
Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies
K Claxton, S Palmer, L Longworth, L Bojke, S Griffin, C McKenna, M Soares, E Spackman, J Youn
Centre for Health Economics
October 2011
Read more here.
No comments:
Post a Comment